TFF Pharmaceuticals, Inc.

Form Type: DEF 14A

Filing Date: 2024-12-23

Corporate Action: Liquidation

Type: New

Accession Number: 000121390024111481

Comments: TFF Pharmaceuticals, Inc. has announced a Special Meeting of Stockholders to be held on January 28, 2025, for the purpose of voting on a proposal for the liquidation and dissolution of the Company under Section 275 of the Delaware General Corporation Law. The Board of Directors unanimously recommends this proposal due to the Company's financial position, lack of revenue sources, and failure to secure financing or explore strategic alternatives. The meeting will require stockholders' approval for the Dissolution and the Plan of Liquidation. If approved, the Company will process assets, settle liabilities, and distribute available proceeds to stockholders, although minimal distributions are anticipated based on the current asset valuation and liabilities. The document details voting procedures, risks, and potential outcomes of the proposal, including implications for stock transfers and tax consequences for stockholders.

Document Link: View Document